

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.99271746 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.80744470 |
| 3 | vocalization behavior (GO:0071625) | 5.77210508 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.68376374 |
| 5 | * neuronal action potential propagation (GO:0019227) | 5.46613664 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.32233850 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.24396472 |
| 8 | glutamate secretion (GO:0014047) | 5.23427068 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.19291597 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.06367691 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 5.03926372 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.98137386 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.92264117 |
| 14 | axon ensheathment in central nervous system (GO:0032291) | 4.90673965 |
| 15 | central nervous system myelination (GO:0022010) | 4.90673965 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.90276632 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.90014287 |
| 18 | gamma-aminobutyric acid transport (GO:0015812) | 4.87325170 |
| 19 | protein localization to synapse (GO:0035418) | 4.86590006 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.81714619 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.76665360 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.70012562 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.69753538 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.69590320 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.67616811 |
| 26 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.63806669 |
| 27 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.43722488 |
| 28 | presynaptic membrane assembly (GO:0097105) | 4.29843289 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.28511689 |
| 30 | C4-dicarboxylate transport (GO:0015740) | 4.27213816 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.19176755 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.10419287 |
| 33 | presynaptic membrane organization (GO:0097090) | 4.07560962 |
| 34 | postsynaptic membrane organization (GO:0001941) | 4.04617868 |
| 35 | positive regulation of membrane potential (GO:0045838) | 4.03425101 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.03066193 |
| 37 | neurotransmitter transport (GO:0006836) | 4.01974293 |
| 38 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.00068326 |
| 39 | long-term memory (GO:0007616) | 3.99563242 |
| 40 | exploration behavior (GO:0035640) | 3.98582355 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.96204729 |
| 42 | L-amino acid import (GO:0043092) | 3.92247189 |
| 43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.86917304 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.78976063 |
| 45 | response to histamine (GO:0034776) | 3.76297761 |
| 46 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.73408441 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 3.71714060 |
| 48 | transmission of nerve impulse (GO:0019226) | 3.69361110 |
| 49 | regulation of neurotransmitter levels (GO:0001505) | 3.68164153 |
| 50 | cerebellar granule cell differentiation (GO:0021707) | 3.63744765 |
| 51 | serotonin metabolic process (GO:0042428) | 3.62555038 |
| 52 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.62536557 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 3.61013449 |
| 54 | long-term synaptic potentiation (GO:0060291) | 3.59186762 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.58149435 |
| 56 | potassium ion import (GO:0010107) | 3.57466823 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.57340101 |
| 58 | startle response (GO:0001964) | 3.55317595 |
| 59 | proline transport (GO:0015824) | 3.54968680 |
| 60 | amino acid import (GO:0043090) | 3.52049855 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.50485341 |
| 62 | cochlea development (GO:0090102) | 3.49316440 |
| 63 | neuron recognition (GO:0008038) | 3.47209208 |
| 64 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.45109100 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.40356855 |
| 66 | cellular sodium ion homeostasis (GO:0006883) | 3.39515220 |
| 67 | primary amino compound metabolic process (GO:1901160) | 3.38120282 |
| 68 | * neuromuscular process controlling posture (GO:0050884) | 3.37552300 |
| 69 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.36821400 |
| 70 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.36683396 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 3.34479945 |
| 72 | regulation of synapse structural plasticity (GO:0051823) | 3.33917714 |
| 73 | membrane hyperpolarization (GO:0060081) | 3.32467985 |
| 74 | * membrane depolarization (GO:0051899) | 3.30996958 |
| 75 | synaptic transmission (GO:0007268) | 3.29080326 |
| 76 | negative regulation of astrocyte differentiation (GO:0048712) | 3.28263631 |
| 77 | neurotransmitter uptake (GO:0001504) | 3.27142377 |
| 78 | activation of protein kinase A activity (GO:0034199) | 3.27057224 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.26231165 |
| 80 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.25761704 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.24711183 |
| 82 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.22477217 |
| 83 | * membrane depolarization during action potential (GO:0086010) | 3.21337702 |
| 84 | glycine transport (GO:0015816) | 3.19074234 |
| 85 | synaptic vesicle endocytosis (GO:0048488) | 3.17686850 |
| 86 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.16665272 |
| 87 | learning (GO:0007612) | 3.16294067 |
| 88 | neuromuscular synaptic transmission (GO:0007274) | 3.16278024 |
| 89 | mechanosensory behavior (GO:0007638) | 3.15775430 |
| 90 | behavioral response to cocaine (GO:0048148) | 3.15432649 |
| 91 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.14088669 |
| 92 | potassium ion homeostasis (GO:0055075) | 3.12067141 |
| 93 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.11708948 |
| 94 | synapse assembly (GO:0007416) | 3.10973172 |
| 95 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.10598168 |
| 96 | regulation of synaptic transmission (GO:0050804) | 3.09791906 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08594951 |
| 98 | * adult walking behavior (GO:0007628) | 3.08088563 |
| 99 | positive regulation of synaptic transmission (GO:0050806) | 3.07653266 |
| 100 | positive regulation of synapse assembly (GO:0051965) | 3.06891158 |
| 101 | layer formation in cerebral cortex (GO:0021819) | 3.06252152 |
| 102 | calcium ion-dependent exocytosis (GO:0017156) | 3.05928217 |
| 103 | striatum development (GO:0021756) | 3.05852166 |
| 104 | neuromuscular process controlling balance (GO:0050885) | 3.04577773 |
| 105 | axonal fasciculation (GO:0007413) | 3.03605023 |
| 106 | negative regulation of dendrite development (GO:2000171) | 3.02825799 |
| 107 | dendritic spine morphogenesis (GO:0060997) | 3.00495938 |
| 108 | regulation of synapse maturation (GO:0090128) | 2.99905225 |
| 109 | sodium ion export (GO:0071436) | 2.99257880 |
| 110 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.98428661 |
| 111 | righting reflex (GO:0060013) | 2.98256547 |
| 112 | * neuromuscular process (GO:0050905) | 2.98225432 |
| 113 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98199430 |
| 114 | long term synaptic depression (GO:0060292) | 2.98083738 |
| 115 | auditory behavior (GO:0031223) | 2.97644951 |
| 116 | response to auditory stimulus (GO:0010996) | 2.97259288 |
| 117 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.96185369 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.92594724 |
| 119 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.89594393 |
| 120 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.89056646 |
| 121 | acidic amino acid transport (GO:0015800) | 2.89041290 |
| 122 | regulation of dendritic spine development (GO:0060998) | 2.88767194 |
| 123 | detection of calcium ion (GO:0005513) | 2.84533965 |
| 124 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.83176292 |
| 125 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.77405114 |
| 126 | cell communication by electrical coupling (GO:0010644) | 2.72994646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.81312441 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.24297269 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.25675555 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.22900144 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12627838 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.88827001 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67319229 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67319229 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65604043 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.61860031 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52868443 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47247221 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.46489576 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.46026674 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45621176 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44251948 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33857319 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.33848380 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31805906 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.19674392 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.15989508 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.15933375 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.13759612 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12761968 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11836396 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11432458 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08225505 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01675256 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01360550 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96617127 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.93091561 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.87229683 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85362121 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81098160 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78069820 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72771752 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70753882 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64030394 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63717396 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.61178675 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.59632903 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58201047 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57082950 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44936527 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.44865109 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44193290 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42352161 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42057053 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41645778 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40309939 |
| 51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39715534 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38963118 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37141600 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36152345 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33555583 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33388471 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32401951 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.31108931 |
| 59 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.30314653 |
| 60 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29893022 |
| 61 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29040861 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27890586 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26678444 |
| 64 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25654198 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25227443 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24648175 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23703526 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.23474733 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21123382 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20403525 |
| 71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17778615 |
| 72 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16518361 |
| 73 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15006505 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14641628 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13824460 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13455676 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12071237 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11227291 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10858681 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09834726 |
| 81 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09067916 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08670450 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08548691 |
| 84 | AR_19668381_ChIP-Seq_PC3_Human | 1.08445930 |
| 85 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06918872 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06463934 |
| 87 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04975003 |
| 88 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04580301 |
| 89 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04105477 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03430821 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03411167 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03411167 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03122750 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02447547 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01699098 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00727865 |
| 97 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00529200 |
| 98 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00234197 |
| 99 | JUN_21703547_ChIP-Seq_K562_Human | 0.99440842 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97994062 |
| 101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94975076 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94007596 |
| 103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92141453 |
| 104 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91697672 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91697672 |
| 106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91463571 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91403382 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90465731 |
| 109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89877533 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89702719 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89351382 |
| 112 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88812895 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87967635 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86983065 |
| 115 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85771746 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.84117960 |
| 117 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83892416 |
| 118 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83889061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.68558059 |
| 2 | MP0003880_abnormal_central_pattern | 5.53913261 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.12240722 |
| 4 | MP0009046_muscle_twitch | 4.08512618 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.54080237 |
| 6 | * MP0002064_seizures | 3.40576617 |
| 7 | MP0004270_analgesia | 3.36482967 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.27277566 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.13336445 |
| 10 | * MP0002272_abnormal_nervous_system | 2.94386350 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.84904935 |
| 12 | MP0003136_yellow_coat_color | 2.76617410 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.73155732 |
| 14 | MP0001486_abnormal_startle_reflex | 2.69452532 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.65982769 |
| 16 | MP0002736_abnormal_nociception_after | 2.62124129 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.61940572 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.57646213 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.55162036 |
| 20 | MP0002822_catalepsy | 2.42677135 |
| 21 | * MP0002067_abnormal_sensory_capabilities | 2.33633137 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.16409692 |
| 23 | MP0008569_lethality_at_weaning | 2.11484069 |
| 24 | MP0002733_abnormal_thermal_nociception | 2.06600158 |
| 25 | MP0001970_abnormal_pain_threshold | 2.05023541 |
| 26 | MP0006276_abnormal_autonomic_nervous | 2.00560983 |
| 27 | MP0002184_abnormal_innervation | 1.90527680 |
| 28 | MP0004142_abnormal_muscle_tone | 1.88624695 |
| 29 | MP0003879_abnormal_hair_cell | 1.85160466 |
| 30 | MP0001188_hyperpigmentation | 1.77225889 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.73864919 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.72658093 |
| 33 | MP0004924_abnormal_behavior | 1.72658093 |
| 34 | MP0003787_abnormal_imprinting | 1.71685327 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.70285362 |
| 36 | MP0001984_abnormal_olfaction | 1.64076958 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.53635864 |
| 38 | MP0003329_amyloid_beta_deposits | 1.50816056 |
| 39 | MP0000778_abnormal_nervous_system | 1.45406551 |
| 40 | * MP0002066_abnormal_motor_capabilities/c | 1.44716072 |
| 41 | MP0001529_abnormal_vocalization | 1.44610962 |
| 42 | MP0000955_abnormal_spinal_cord | 1.43975631 |
| 43 | MP0003122_maternal_imprinting | 1.43098270 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.37491867 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.35543033 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.28371444 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.24050167 |
| 48 | MP0003633_abnormal_nervous_system | 1.22903359 |
| 49 | MP0001905_abnormal_dopamine_level | 1.21938059 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.21223843 |
| 51 | MP0004145_abnormal_muscle_electrophysio | 1.20774249 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.18264052 |
| 53 | MP0004858_abnormal_nervous_system | 1.16128174 |
| 54 | MP0003646_muscle_fatigue | 1.16027424 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.15018001 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.09804125 |
| 57 | MP0002229_neurodegeneration | 1.08554112 |
| 58 | MP0004742_abnormal_vestibular_system | 1.07751917 |
| 59 | MP0003631_nervous_system_phenotype | 1.04673418 |
| 60 | MP0004885_abnormal_endolymph | 1.04400934 |
| 61 | MP0005187_abnormal_penis_morphology | 1.03969151 |
| 62 | MP0003690_abnormal_glial_cell | 1.03865797 |
| 63 | MP0008872_abnormal_physiological_respon | 1.02664875 |
| 64 | MP0005253_abnormal_eye_physiology | 1.02337713 |
| 65 | MP0000751_myopathy | 1.02234991 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.00234347 |
| 67 | MP0002653_abnormal_ependyma_morphology | 0.97408583 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 0.96663477 |
| 69 | * MP0002152_abnormal_brain_morphology | 0.96466661 |
| 70 | MP0002638_abnormal_pupillary_reflex | 0.95292097 |
| 71 | MP0002102_abnormal_ear_morphology | 0.93481345 |
| 72 | MP0003123_paternal_imprinting | 0.90856608 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.90557370 |
| 74 | MP0006072_abnormal_retinal_apoptosis | 0.90320307 |
| 75 | MP0008874_decreased_physiological_sensi | 0.85999623 |
| 76 | MP0001485_abnormal_pinna_reflex | 0.84038481 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.82837289 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.80478427 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.80422216 |
| 80 | MP0004484_altered_response_of | 0.79803064 |
| 81 | MP0006292_abnormal_olfactory_placode | 0.79531583 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.79105267 |
| 83 | MP0008877_abnormal_DNA_methylation | 0.78549121 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.78106212 |
| 85 | MP0005409_darkened_coat_color | 0.77628289 |
| 86 | MP0004147_increased_porphyrin_level | 0.75676272 |
| 87 | MP0000566_synostosis | 0.73440868 |
| 88 | MP0005394_taste/olfaction_phenotype | 0.72533859 |
| 89 | MP0005499_abnormal_olfactory_system | 0.72533859 |
| 90 | MP0003632_abnormal_nervous_system | 0.72252083 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.71899955 |
| 92 | MP0001177_atelectasis | 0.71620934 |
| 93 | MP0005535_abnormal_body_temperature | 0.70869172 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.68425514 |
| 95 | MP0004085_abnormal_heartbeat | 0.68112442 |
| 96 | MP0008260_abnormal_autophagy | 0.66135722 |
| 97 | MP0003195_calcinosis | 0.65564267 |
| 98 | MP0004133_heterotaxia | 0.65538906 |
| 99 | MP0000920_abnormal_myelination | 0.65327422 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.65162046 |
| 101 | MP0003121_genomic_imprinting | 0.64356654 |
| 102 | MP0003861_abnormal_nervous_system | 0.63319915 |
| 103 | MP0003634_abnormal_glial_cell | 0.63232346 |
| 104 | MP0002938_white_spotting | 0.62897763 |
| 105 | MP0001664_abnormal_digestion | 0.59424189 |
| 106 | MP0000026_abnormal_inner_ear | 0.58215077 |
| 107 | MP0000015_abnormal_ear_pigmentation | 0.58047267 |
| 108 | MP0002751_abnormal_autonomic_nervous | 0.57694745 |
| 109 | MP0002928_abnormal_bile_duct | 0.56665301 |
| 110 | MP0005171_absent_coat_pigmentation | 0.56525557 |
| 111 | MP0004043_abnormal_pH_regulation | 0.56295591 |
| 112 | MP0005195_abnormal_posterior_eye | 0.55854866 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.54951723 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.54583237 |
| 115 | * MP0010769_abnormal_survival | 0.53298527 |
| 116 | MP0000604_amyloidosis | 0.52513824 |
| 117 | * MP0002082_postnatal_lethality | 0.51958420 |
| 118 | * MP0010770_preweaning_lethality | 0.51958420 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.51466610 |
| 120 | * MP0010768_mortality/aging | 0.51102025 |
| 121 | MP0003698_abnormal_male_reproductive | 0.50831402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Focal motor seizures (HP:0011153) | 9.12596589 |
| 2 | Myokymia (HP:0002411) | 6.45737294 |
| 3 | * Focal seizures (HP:0007359) | 5.93013074 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.83189440 |
| 5 | * Febrile seizures (HP:0002373) | 5.52672472 |
| 6 | * Atonic seizures (HP:0010819) | 5.44771453 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.97968607 |
| 8 | Visual hallucinations (HP:0002367) | 4.93361620 |
| 9 | Gaze-evoked nystagmus (HP:0000640) | 4.42471101 |
| 10 | * Absence seizures (HP:0002121) | 4.38771646 |
| 11 | Action tremor (HP:0002345) | 4.21035563 |
| 12 | Hyperventilation (HP:0002883) | 4.16999367 |
| 13 | * Dialeptic seizures (HP:0011146) | 4.14072709 |
| 14 | Broad-based gait (HP:0002136) | 3.98354191 |
| 15 | * Generalized tonic-clonic seizures (HP:0002069) | 3.78100279 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.56188736 |
| 17 | Progressive inability to walk (HP:0002505) | 3.46121736 |
| 18 | Scanning speech (HP:0002168) | 3.41350219 |
| 19 | Truncal ataxia (HP:0002078) | 3.38071384 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.35554055 |
| 21 | Poor eye contact (HP:0000817) | 3.18313425 |
| 22 | Dysmetria (HP:0001310) | 3.12950916 |
| 23 | Abnormal social behavior (HP:0012433) | 3.01099249 |
| 24 | Impaired social interactions (HP:0000735) | 3.01099249 |
| 25 | Depression (HP:0000716) | 2.98237745 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.94605856 |
| 27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.93207965 |
| 28 | Impaired smooth pursuit (HP:0007772) | 2.91472518 |
| 29 | Amblyopia (HP:0000646) | 2.86254123 |
| 30 | Anxiety (HP:0000739) | 2.83155225 |
| 31 | Genetic anticipation (HP:0003743) | 2.82963939 |
| 32 | Diplopia (HP:0000651) | 2.82930051 |
| 33 | Abnormality of binocular vision (HP:0011514) | 2.82930051 |
| 34 | Inability to walk (HP:0002540) | 2.81342809 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.77009337 |
| 36 | Ankle clonus (HP:0011448) | 2.75528301 |
| 37 | True hermaphroditism (HP:0010459) | 2.74320677 |
| 38 | Polyphagia (HP:0002591) | 2.69263611 |
| 39 | Abnormal hair whorl (HP:0010721) | 2.64860036 |
| 40 | Fetal akinesia sequence (HP:0001989) | 2.62087646 |
| 41 | Dysmetric saccades (HP:0000641) | 2.62032626 |
| 42 | Absent speech (HP:0001344) | 2.59059116 |
| 43 | Pheochromocytoma (HP:0002666) | 2.57483784 |
| 44 | Epileptiform EEG discharges (HP:0011182) | 2.53779108 |
| 45 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.52518093 |
| 46 | Neuroendocrine neoplasm (HP:0100634) | 2.43704218 |
| 47 | Drooling (HP:0002307) | 2.43226060 |
| 48 | Excessive salivation (HP:0003781) | 2.43226060 |
| 49 | Postural instability (HP:0002172) | 2.38176433 |
| 50 | Bradykinesia (HP:0002067) | 2.37619128 |
| 51 | Failure to thrive in infancy (HP:0001531) | 2.36228200 |
| 52 | Mutism (HP:0002300) | 2.35170831 |
| 53 | Postural tremor (HP:0002174) | 2.34204043 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29749471 |
| 55 | Spastic gait (HP:0002064) | 2.28738848 |
| 56 | * Hemiplegia (HP:0002301) | 2.23440528 |
| 57 | Stereotypic behavior (HP:0000733) | 2.23404515 |
| 58 | * Status epilepticus (HP:0002133) | 2.23339484 |
| 59 | Gait imbalance (HP:0002141) | 2.20945932 |
| 60 | Urinary urgency (HP:0000012) | 2.18535549 |
| 61 | Protruding tongue (HP:0010808) | 2.18280350 |
| 62 | Impaired vibratory sensation (HP:0002495) | 2.16004088 |
| 63 | Nephronophthisis (HP:0000090) | 2.15362001 |
| 64 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.12393835 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.12393835 |
| 66 | Esotropia (HP:0000565) | 2.12046465 |
| 67 | Annular pancreas (HP:0001734) | 2.11617964 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.11613612 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.11501200 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.09199334 |
| 71 | Poor suck (HP:0002033) | 2.08598361 |
| 72 | Intention tremor (HP:0002080) | 2.06794192 |
| 73 | Delusions (HP:0000746) | 2.03211060 |
| 74 | Horizontal nystagmus (HP:0000666) | 2.03051829 |
| 75 | Blue irides (HP:0000635) | 2.02270747 |
| 76 | Pancreatic cysts (HP:0001737) | 2.01492214 |
| 77 | Gait ataxia (HP:0002066) | 2.00496407 |
| 78 | Limb dystonia (HP:0002451) | 1.99728447 |
| 79 | Specific learning disability (HP:0001328) | 1.99613864 |
| 80 | Focal dystonia (HP:0004373) | 1.98250991 |
| 81 | Congenital primary aphakia (HP:0007707) | 1.98225103 |
| 82 | Torticollis (HP:0000473) | 1.96150821 |
| 83 | Psychosis (HP:0000709) | 1.95323852 |
| 84 | Abnormality of saccadic eye movements (HP:0000570) | 1.94571197 |
| 85 | Large for gestational age (HP:0001520) | 1.93782070 |
| 86 | Medial flaring of the eyebrow (HP:0010747) | 1.93774697 |
| 87 | Abnormality of midbrain morphology (HP:0002418) | 1.93129072 |
| 88 | Molar tooth sign on MRI (HP:0002419) | 1.93129072 |
| 89 | Hepatoblastoma (HP:0002884) | 1.91719403 |
| 90 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90892970 |
| 91 | Optic nerve hypoplasia (HP:0000609) | 1.90384258 |
| 92 | Acute necrotizing encephalopathy (HP:0006965) | 1.90280359 |
| 93 | Incomplete penetrance (HP:0003829) | 1.89900886 |
| 94 | Agitation (HP:0000713) | 1.89189356 |
| 95 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88068808 |
| 96 | Megalencephaly (HP:0001355) | 1.87888275 |
| 97 | Lower limb muscle weakness (HP:0007340) | 1.86188123 |
| 98 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.85023034 |
| 99 | Abnormality of the labia minora (HP:0012880) | 1.84684203 |
| 100 | Abnormality of the corticospinal tract (HP:0002492) | 1.84215396 |
| 101 | Absent/shortened dynein arms (HP:0200106) | 1.83866166 |
| 102 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.83866166 |
| 103 | Insidious onset (HP:0003587) | 1.83650202 |
| 104 | Termporal pattern (HP:0011008) | 1.83650202 |
| 105 | Iris hypopigmentation (HP:0007730) | 1.83604947 |
| 106 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83598006 |
| 107 | Limb ataxia (HP:0002070) | 1.83547459 |
| 108 | Spastic tetraplegia (HP:0002510) | 1.82468558 |
| 109 | Glioma (HP:0009733) | 1.79637087 |
| 110 | Sleep apnea (HP:0010535) | 1.79616549 |
| 111 | Abnormality of the lower motor neuron (HP:0002366) | 1.79222211 |
| 112 | Polydipsia (HP:0001959) | 1.78516238 |
| 113 | Abnormal drinking behavior (HP:0030082) | 1.78516238 |
| 114 | Progressive macrocephaly (HP:0004481) | 1.78334266 |
| 115 | Unsteady gait (HP:0002317) | 1.77917603 |
| 116 | * Hemiparesis (HP:0001269) | 1.77730580 |
| 117 | Ulnar claw (HP:0001178) | 1.77111446 |
| 118 | Abnormality of the renal medulla (HP:0100957) | 1.74961465 |
| 119 | Split foot (HP:0001839) | 1.74909543 |
| 120 | Narrow nasal bridge (HP:0000446) | 1.71816405 |
| 121 | Bronchomalacia (HP:0002780) | 1.71807742 |
| 122 | Hypoventilation (HP:0002791) | 1.71464488 |
| 123 | Clonus (HP:0002169) | 1.70725672 |
| 124 | Neuronal loss in central nervous system (HP:0002529) | 1.70578737 |
| 125 | * Generalized myoclonic seizures (HP:0002123) | 1.70454120 |
| 126 | Neurofibrillary tangles (HP:0002185) | 1.69258196 |
| 127 | Heterochromia iridis (HP:0001100) | 1.69238925 |
| 128 | Type II lissencephaly (HP:0007260) | 1.68799549 |
| 129 | Decreased central vision (HP:0007663) | 1.67198515 |
| 130 | Genital tract atresia (HP:0001827) | 1.66895236 |
| 131 | Epidermoid cyst (HP:0200040) | 1.66522558 |
| 132 | Lissencephaly (HP:0001339) | 1.66318700 |
| 133 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.64917363 |
| 134 | Hypoplasia of the corpus callosum (HP:0002079) | 1.60977218 |
| 135 | Vaginal atresia (HP:0000148) | 1.58994669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.78332397 |
| 2 | CASK | 4.05628457 |
| 3 | MAP2K7 | 3.67014096 |
| 4 | EPHA4 | 3.63518495 |
| 5 | MAP3K4 | 3.41341034 |
| 6 | MAP3K9 | 3.18971468 |
| 7 | MAP3K12 | 3.12034525 |
| 8 | TNIK | 2.45620882 |
| 9 | FRK | 2.41192702 |
| 10 | CDK19 | 2.39985788 |
| 11 | MINK1 | 2.38575469 |
| 12 | DAPK2 | 2.33926809 |
| 13 | MAP2K4 | 2.30191151 |
| 14 | RIPK4 | 2.09026583 |
| 15 | NTRK2 | 1.90353519 |
| 16 | CAMKK2 | 1.79181003 |
| 17 | MAPK15 | 1.79161684 |
| 18 | MARK1 | 1.78993957 |
| 19 | WNK4 | 1.68501726 |
| 20 | DAPK1 | 1.65105030 |
| 21 | PAK6 | 1.60694221 |
| 22 | ARAF | 1.59925368 |
| 23 | CAMKK1 | 1.56006670 |
| 24 | STK39 | 1.55471482 |
| 25 | PLK2 | 1.54001469 |
| 26 | PNCK | 1.46149263 |
| 27 | MAPK13 | 1.44339244 |
| 28 | CCNB1 | 1.40076108 |
| 29 | STK38 | 1.37765078 |
| 30 | NTRK1 | 1.32760200 |
| 31 | GRK5 | 1.32730827 |
| 32 | SGK2 | 1.32028372 |
| 33 | CDK5 | 1.31976710 |
| 34 | PRKCG | 1.31037708 |
| 35 | PRPF4B | 1.29749413 |
| 36 | KSR2 | 1.28843857 |
| 37 | FES | 1.25315405 |
| 38 | AKT3 | 1.20732624 |
| 39 | SGK223 | 1.17902367 |
| 40 | SGK494 | 1.17902367 |
| 41 | OXSR1 | 1.15978840 |
| 42 | MUSK | 1.10809994 |
| 43 | PAK3 | 1.09919691 |
| 44 | BMPR1B | 1.08200036 |
| 45 | KSR1 | 1.03669998 |
| 46 | CAMK2A | 1.02154660 |
| 47 | TNK2 | 0.97563237 |
| 48 | BMPR2 | 0.91438766 |
| 49 | CAMK1 | 0.90852808 |
| 50 | FGFR2 | 0.89103811 |
| 51 | CAMK2B | 0.88819923 |
| 52 | NME1 | 0.88287373 |
| 53 | BCR | 0.87340934 |
| 54 | WNK1 | 0.86594283 |
| 55 | SIK2 | 0.85002966 |
| 56 | PKN1 | 0.84392411 |
| 57 | SGK3 | 0.83658437 |
| 58 | MAP3K13 | 0.82807281 |
| 59 | UHMK1 | 0.81669123 |
| 60 | DYRK1A | 0.81236050 |
| 61 | WEE1 | 0.80526768 |
| 62 | CSNK1A1L | 0.79991935 |
| 63 | BRAF | 0.78620823 |
| 64 | PINK1 | 0.78176951 |
| 65 | STK11 | 0.77595422 |
| 66 | CSNK1G3 | 0.77268584 |
| 67 | PRKD3 | 0.73804344 |
| 68 | CDK18 | 0.72007569 |
| 69 | CDK15 | 0.69283281 |
| 70 | PHKG2 | 0.68707927 |
| 71 | PHKG1 | 0.68707927 |
| 72 | MAP4K2 | 0.68019184 |
| 73 | CAMK1G | 0.67565363 |
| 74 | CAMK4 | 0.67381223 |
| 75 | CDK14 | 0.67268235 |
| 76 | RAF1 | 0.65015630 |
| 77 | CSNK1G2 | 0.63307201 |
| 78 | MAPKAPK5 | 0.62354422 |
| 79 | SGK1 | 0.62332477 |
| 80 | PRKCE | 0.61841870 |
| 81 | GRK7 | 0.61696999 |
| 82 | CDK11A | 0.61683738 |
| 83 | TAOK1 | 0.60848220 |
| 84 | CAMK2G | 0.60633717 |
| 85 | LATS2 | 0.60581583 |
| 86 | PIK3CA | 0.59796137 |
| 87 | MKNK2 | 0.59423396 |
| 88 | MAP3K1 | 0.58373794 |
| 89 | CAMK1D | 0.57684221 |
| 90 | PRKCH | 0.57128532 |
| 91 | ACVR1B | 0.57108725 |
| 92 | EPHA3 | 0.56532896 |
| 93 | DYRK2 | 0.56258126 |
| 94 | PDK3 | 0.54886198 |
| 95 | PDK4 | 0.54886198 |
| 96 | GRK1 | 0.54257366 |
| 97 | ERBB2 | 0.52301830 |
| 98 | CAMK2D | 0.50583337 |
| 99 | INSRR | 0.50517135 |
| 100 | MAP3K6 | 0.49441411 |
| 101 | PRKG1 | 0.49269255 |
| 102 | PDK1 | 0.49235771 |
| 103 | PDPK1 | 0.47350907 |
| 104 | TYRO3 | 0.46484394 |
| 105 | CSNK1D | 0.46356067 |
| 106 | TSSK6 | 0.44605247 |
| 107 | LMTK2 | 0.43892285 |
| 108 | NEK6 | 0.43855397 |
| 109 | MAP3K2 | 0.41189189 |
| 110 | BRSK1 | 0.39777548 |
| 111 | RPS6KA3 | 0.38739373 |
| 112 | CDK3 | 0.38030441 |
| 113 | WNK3 | 0.37687056 |
| 114 | PTK2B | 0.36202886 |
| 115 | PRKACA | 0.35136713 |
| 116 | RET | 0.34727305 |
| 117 | MAPK10 | 0.34239507 |
| 118 | ROCK1 | 0.33827761 |
| 119 | VRK1 | 0.33649294 |
| 120 | ADRBK2 | 0.33477564 |
| 121 | FER | 0.33010603 |
| 122 | CSNK1A1 | 0.32159661 |
| 123 | ROCK2 | 0.31625709 |
| 124 | CSNK1G1 | 0.29616852 |
| 125 | MAPK12 | 0.29276868 |
| 126 | PRKCZ | 0.29223567 |
| 127 | PRKCA | 0.28756218 |
| 128 | ADRBK1 | 0.28617071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.72428250 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.88111345 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.07301001 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.00258290 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.73151206 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.72997322 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67379239 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67315182 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.64479781 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.44830282 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.39753191 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.28504819 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.21811635 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09613616 |
| 15 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05800137 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.93610707 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.85428756 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77026831 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71222528 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70071477 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69501856 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64636011 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58410800 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.54602169 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49860126 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49493846 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46341353 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41471517 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39355607 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.38199903 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37546590 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33498436 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31242281 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29757622 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25358454 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22595958 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19486004 |
| 38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18658859 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.18207541 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16377434 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12177974 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11754486 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.09265978 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07716125 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06532463 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94562742 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 0.90933601 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90681447 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90064044 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88371428 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87585563 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87423587 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.86082220 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85562503 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84821032 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84587355 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83671177 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82848481 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82331717 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77775023 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.75769536 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74349783 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73842948 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70305683 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.69263979 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68568095 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68074019 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65968598 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.64277347 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63058322 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62199371 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62021807 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60971432 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59810873 |
| 75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59275429 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59033775 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58916042 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58853440 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58365271 |
| 80 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57438959 |
| 81 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56844234 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56300500 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.53961897 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53926062 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50431062 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49529365 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48999382 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48689195 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48528713 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47903922 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47835084 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47441710 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46957651 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45331540 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44352256 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43444875 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41312585 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40191476 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38344860 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38051042 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37932767 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36849880 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35229510 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.34966373 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34485450 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34447657 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34143717 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33940046 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32696893 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31778855 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.30818747 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29973179 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29939683 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.29512331 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29199574 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27827059 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27713422 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27125442 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.26971627 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.25267366 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24899674 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24459479 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.23846490 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23717639 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22974788 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22213851 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.17026476 |

